Research Awards Banner.png

Jump to... 

Contact us...

  • Email LSO@vanderbilt.edu if you are interested in an opportunity not listed below or have questions regarding the LSO submission process.

 


Active Internal Calls for Limited Submission Nominations 

Internal review process required to choose institutional nominees


Limited Submission Eligibility Guidelines

The following tags serve as a guide for submission instructions.

 Vanderbilt (VU + VUMC):  

  • VU and VUMC submit collaboratively to this LSO. ALL investigators should follow the guidelines posted on this site.

 VUMC :

  • VU and VUMC submit separately to this LSO. VUMC investigators should follow the guidelines posted on this site. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

FEATURED OPPORTUNITY

  • High-profile or prestigious awards of particular interest to Vanderbilt investigators

 

2020 Takeda Innovators in Science Award- Rare Diseases

Applications due October 15

 VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

Overview:

VUMC may nominate 1 Early Career Scientist and 1 Senior Scientist in a field of Rare Diseases for the 2020 Innovators in Science Award, sponsored by Takeda Pharmaceutical Company Limited and administered by the New York Academy of Sciences.  This year’s award competition is focused on the therapeutic area of Rare Diseases.  Awardees will receive $200,000.

Each nominee will be evaluated based on the quality of their research, the impact of their research on human health, the novelty of their ideas and methods, and the promise they show for future contributions to their field.  Full guidelines and review criteria are found on the program website.

Eligibility Criteria:

Note: Individuals in receipt of current or prior research support from Takeda Pharmaceutical Company Limited, or its affiliates, are not eligible for nomination.

Early Career Scientist nominees must…

  • Currently hold a junior level Post-doctoral or Faculty position.
  • Have been engaged in active research for 10 years or less since gaining their doctorate degree. (Eligibility extension may be requested for exceptional circumstances.)
  • Hold a doctorate degree (PhD, DPhil, MD, DDS, DVM, etc.).
  • Have made impactful research contributions and show exceptional promise for significant future achievement in one of the rare disease sub-disciplines (below).

Senior Scientist nominees must…

  • Currently hold a senior level Faculty position.
  • Have been engaged in active research for more than 10 years since gaining their doctorate degree.
  • Hold a doctorate degree (PhD, DPhil, MD, DDS, DVM, etc.).
  • Have made multiple, extensive, and impactful research contributions to advance one of the rare disease sub-disciplines (below).

Rare Disease Sub-Disciplines:

  • Autoimmune / Autoinflammatory Diseases
  • Bacterial Infections Blood Diseases
  • Chromosome Disorders
  • Congenital and Genetic Diseases
  • Connective Tissue Diseases
  • Digestive Diseases
  • Ear, Nose, and Throat Diseases
  • Endocrine Diseases
  • Eye Diseases
  • Female Reproductive Diseases
  • Fungal Infections Heart Diseases
  • Hereditary Cancer Syndromes
  • Immune System Diseases
  • Kidney and Urinary Diseases
  • Lung Diseases Male Reproductive Diseases
  • Metabolic Disorders Mouth Diseases
  • Musculoskeletal Diseases
  • Nervous System Diseases
  • Newborn Screening Nutritional Diseases
  • Parasitic Diseases
  • Rare Cancers Skin Diseases
  • Viral Infections
  • Other

Internal Application Process:

Please submit the following (in a single PDF) to LSO@vanderbilt.edu by 5 p.m. on October 15, 2019. Contact LSO@vanderbilt.edu with any questions.

  1. Nominee’s Sub-Discipline of Rare Disease (see list above)
  2. Research Summary (1,000 word max)
  3. Future Research Plan (500 word max) *required for Early Career Scientist nominees only
  4. Biosketch/CV (4 page max)
  5. Letter of support from Department Chair/ Center Director.

2020 Creating Opportunity and Independence Awards

Applications due October 18

 VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

Vanderbilt University may submit one application to the Craig H. Neilsen Foundation for the Creating Opportunity and Independence program. The goal of the Creating Opportunity & Independence (CO & I) program is to enhance the quality of life for individuals and their families living with spinal cord injury. CO & I grants support innovative programs/projects that improve participation and independence for individuals living with SCI and address critical areas of need in rehabilitation, transitional stages, and in the community.

CO & I grant support includes, but is not limited to, access to assistive technology, rehabilitation programs and clinical equipment, transportation, arts initiatives, adaptive sports and recreation programs, home modifications, adaptive driving, vocational programs, initiatives in education, and patient assistance programs. The Neilsen Foundation is interested in projects that have broad impact, affect people across the lifespan, demonstrate community partnerships and empower individuals with SCI by providing options and opportunities to achieve greater independence.

Funding amounts range from $25,000 to $100,000. Grants may be multi-year, and funding for each subsequent year is contingent on a favorable review of an annual progress and expenditure report. The maximum amount allowed for indirect costs is 10% of the total cost.

See last year's guidelines for more information.

Internal Application Process:

Eligible faculty interested in being one of VUMC’s nominees must submit the following (in a single PDF) to LSO@vanderbilt.edu  by 5 p.m. on October 18, 2019.

  1. Brief (2-page maximum) research plan including summary budget (IDC may not exceed 10%). Your project description should address the following:
    1. The relevance of the proposed project to the mission of the Neilsen Foundation and the potential impact on the SCI (spinal cord injury) community
    2. Feasibility of the project
    3. Community partnerships (if any)
  2. NIH Biosketch
  3. Letter of support from department chair/center director

Any questions about this LSO may be directed to LSO@vanderbilt.edu  


2020 ORAU Ralph E. Powe Junior Faculty Enhancement Awards

Applications due October 23

Vanderbilt (VU + VUMC): This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions.

Vanderbilt (VU & VUMC combined) can nominate up to 2 assistant professors for the 2020 Ralph E. Powe Junior Faculty Enhancement Awards, sponsored by Oak Ridge Associated Universities (ORAU). The awards provide seed money for research intended to enrich the research and professional growth of young faculty.  The award amount is $5,000, which can be used for faculty summer salary, graduate student salary, travel, equipment, or other assistance relevant to the faculty member’s research, but indirect costs are not allowed.  Because of the close working relationship between ORAU and Oak Ridge National Laboratory (ORNL), the Award Committee particularly encourages collaborative interaction with ORNL.

IMPORTANT NOTE: The applicant’s institution is required to match the award with at least an additional $5,000. Applicants must work with the appropriate Dean, Department Chair, or Center Director to obtain a commitment to these matching funds.

Eligibility:

Awards are restricted to full-time assistant professors within 2 years of their initial tenure track appointment by the nomination date (January 8, 2020). ORAU will recognize circumstances that resulted in a “tenure clock delay”. Faculty research projects must be in one of the following disciplines: 

  • Engineering and Applied Science
  • Life Sciences
  • Mathematics/Computer Sciences
  • Physical Sciences
  • Policy, Management, or Education

All applicants should verify their eligibility in advance through the foundation FAQs. A list of award recipients from 2019 can be found here.

Internal Application Process:

Anyone interested in being considered as Vanderbilt’s potential nominee must submit the below items (in PDF format) to LSO@vanderbilt.edu by 5 p.m. on October 23, 2019.  Submissions should reference the program name in the subject line of the email. Please adhere to the ORAU application instructions as much as possible.

  1. Brief research plan including summary budget (2 page max, including budget);
  2. Statement of support from Dean, department chair, or center director
    1. Letter must include a school, department, or center commitment to the REQUIRED $5,000 in matching funds;
    2. Letter must acknowledge that this grant does not allow indirect costs.** This statement can be used/modified: “The Department recognizes that this grant does not allow indirect costs and will commit to covering any associated indirect costs per applicable institutional policy.”
  3. NIH Biosketch or Brief CV (5 page max)

**Process for cost-sharing typically coordinated at the departmental level and approved by department chair and/or dean. Please consult LSO@vanderbilt.edu for further guidance.

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


2020 Mallinckrodt Scholars ProgramFEATURED OPPORTUNITY

Applications due October 24

Vanderbilt (VU + VUMC): This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions.

Vanderbilt (VU and VUMC, collaboratively) anticipates the opportunity to nominate two candidates for the Edward Mallinckrodt, Jr Foundation Scholar Award Program. The Foundation supports early stage investigators engaged in biomedical research that has the potential to significantly advance the understanding, diagnosis, or treatment of disease. This award typically provides $400,000 over four years in order to move a project forward to the point where other independent funding can be obtained.

Eligibility:

  • Hold M.D. and/or Ph.D. degree
  • In 5th to 8th year of a tenure-track position
  • Candidates may have an R01

Internal Application Process:

Anyone interested in being considered as Vanderbilt’s potential nominee must submit the following (in PDF format) to LSO@vanderbilt.edu by 5 p.m. on October 24, 2019

  1. Brief research lay summary (1/2 page max);
  2. Brief research plan including summary budget (2 page max including budget);
  3. Letter of support from department chair/center director;
    1. Letter must acknowledge that this grant does not allow indirect costs.** This statement can be used/modified: “The Department recognizes that this grant does not allow indirect costs and will commit to covering any associated indirect costs per applicable institutional policy.”
  4. NIH Biosketch or Brief CV (5 page max)

**Process for cost-sharing typically coordinated at the departmental level and approved by department chair and/or dean. Please consult LSO@vanderbilt.edu for further guidance.

Submissions should reference the program name in the subject line of the email. All applicants should verify their eligibility in advance through the foundation website.

Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


NSF Major Research Instrumentation (MRI) Program

Applications due October 31

 VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu

VUMC may submit up to 3 proposals for the NSF Major Research Instrumentation (MRI) Program, which serves to increase access to multi-user scientific and engineering instrumentation for research and research training. An MRI award supports the acquisition or development of a multi-user research instrument that is too costly and/or not appropriate for support through other NSF programs.

MRI provides support to acquire critical research instrumentation without which advances in fundamental science and engineering research may not otherwise occur. MRI also provides support to develop next-generation research instruments that open new opportunities to advance the frontiers in science and engineering research. Additionally, an MRI award is expected to enhance research training of students who will become the next generation of instrument users, designers and builders.

An MRI proposal may request up to $4 million for either acquisition or development of a research instrument. VUMC is limited to 3 total submissions across the two tracks below, with no more than two submissions in Track 1 and no more than one submission in Track 2.

  • Track 1: MRI proposals that request $100,000 – less than $1,000,000
  • Track 2: MRI proposals that request $1,000,000 - $4,000,000

Eligibility:

  • Please consult the Program Description (Section II.A-B) for a detailed description of project types and fields of science that are eligible for funding.
  • The MRI Program seeks broad representation by PIs in its award portfolio, including women, underrepresented minorities and persons with disabilities. The MRI program also encourages proposals with early-career PIs and proposals that benefit early-career researchers.
  • IMPORTANT NOTE: For either track, Cost-sharing of precisely 30% of the total project cost is required! Inclusion of voluntary committed cost-sharing is prohibited.

Internal Application Process:

Anyone interested in being considered to submit one of VUMC’s proposals must submit the following (in a single PDF) to LSO@vanderbilt.edu by 5 p.m. on October 31, 2019:

  1. Brief (2 page maximum) project description including summary budget
  2. Brief statement of support from department chair/center director including a department or center commitment to the REQUIRED 30% cost-sharing
  3. NIH Biosketch

Please review the solicitation and the FAQs for more information regarding the program. Following the internal process, the full proposal is due to NSF by January 21, 2020. Any questions about this opportunity may be directed to LSO@vanderbilt.edu.


2020 Brain Research Foundation Fay/Frank Seed Grant Program

Applications due October 31

Vanderbilt (VU + VUMC): This is a joint competition for VU and VUMC investigators. All investigators should follow these instructions.

Vanderbilt (VU and VUMC, collaboratively) has the opportunity to nominate one candidate for the Brain Research Foundation Fay/Frank Seed Grant Program for 2020. This award provides $80,000 (direct costs) over two years to support new research projects in the field of neuroscience that will likely lead to extramural funding from the National Institutes of Health (NIH) or other outside funding sources. The objective of the BRF Seed Grant Program is to support new and innovative projects, especially those of junior faculty, who are working in new research directions. Funds must be utilized within the grant period.

Eligibility:

  • PI must be a full-time Assistant or Associate Professor working in the area of studies of brain function. This includes molecular and clinical neuroscience as well as studies of neural, sensory, motor, cognitive, behavioral and emotional functioning in health and disease.
    • Assistant Professor – Junior faculty with a new research project that will generate pilot data that will lead to R01 funding or a comparable outside grant will be first priority.  Must provide abstract and specific aims for current grants and indicate if there is any overlap.
    • Associate Professor – Faculty who are pursuing new research directions. Must explain how the project is a new research direction. Must provide abstract and specific aims for current grant(s) and indicate if there is any overlap.
  • Research assistant professors, research associate professors, and Full Professors are not eligible.
  • The grant proposal must detail a new research project that is not funded by other sources.

Internal Application Process:

Anyone interested in being considered as Vanderbilt’s potential nominee must submit the following (in PDF format) to LSO@vanderbilt.edu by 5 p.m. on October 31, 2019

  1. Brief research plan including summary budget (2 page max including budget);
    • Include closing paragraph that explains how this research will develop (next steps)
    • Refer to budget guidelines
  2. Statement of support from department chair/center director;
    • Letter must acknowledge that this grant does not allow indirect costs.** This statement can be used/modified: “The Department recognizes that this grant does not allow indirect costs and will commit to covering any associated indirect costs per applicable institutional policy.”
  3. CV or NIH Biosketch (5 page max)

Submissions should reference the program name in the subject line of the email. All applicants should verify their eligibility in advance through the foundation website. Vanderbilt’s nominee will submit a required LOI by January 7, 2020. Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


NIH Collaborative Program Grant for Multidisciplinary Teams (RM1)

 VUMC:  These instructions are for VUMC investigators. VU investigators should apply through InfoReady and address any questions to VU-LSO@vanderbilt.edu.

Applications due November 12

Overview:

VUMC may submit one proposal for the January 2020 cycle of the NIH Collaborative Program Grant for Multidisciplinary Teams (RM1). The program is designed to support highly integrated research teams of three to six PD/PIs to address ambitious and challenging research questions that are important for the mission of National Institute of General Medical Sciences (NIGMS). Collaborative program teams are expected to accomplish goals that require considerable synergy and managed team interactions. Project goals should not be achievable with a collection of individual efforts or projects. While applications may request research program budgets of up to $1.5 million direct costs per year, it is anticipated that most awards will be between $700,000-$900,000 direct costs.

Eligibility:

Applications may address any area of science within the NIGMS mission, which is to support basic research that increases understanding of biological processes at a range of levels, from molecules and cells to tissues, whole organisms and populations. NIGMS also supports research in a limited number of clinical areas that affect multiple organ systems (see here for scientific areas supported by NIGMS).

We recommend that applicants review the RFA in detail to review the research areas that are within the NIGMS mission. Applications that focus solely on a specific organ or disease state and that are within the mission areas of other NIH Institutes and Centers are not appropriate for this FOA. Applications that employ specific cells or tissues to address a fundamental biomedical question are appropriate.

Applications that are mainly focused on the creation, expansion, and/or maintenance of community resources, creation of new technologies or infrastructure development are not appropriate for this FOA. NIH-defined clinical trials are not allowed.

Internal Application Process:

Anyone interested in being considered to submit VUMC’s proposal must submit the following (in a single PDF) to LSO@vanderbilt.edu by 5 p.m. on November 12, 2019:

  • Brief project description including summary budget and role of each PI (2 page max);
  • Letter of support from department chair/center director;
  • NIH Biosketch for all PIs

Full applications are due to NIH by January 25, with an LOI requested 30 days prior. Any questions about this opportunity or the LSO process may be directed to LSO@vanderbilt.edu.


Active Calls for NON-Limited External Opportunities 

Internal review process NOT required- Submit directly to Sponsor

The VUMC Corporate & Foundation Relations team provides hands-on proposal development assistance for non-federal awards. Contact cfr@vumc.org for more information.


American Cancer Society Research & Training Grants- Multiple Award Types

Applications due October 15

The American Cancer Society is accepting research and training grant applications with a submission deadline of October 15.

The American Cancer Society primarily supports beginning investigators. The ACS also offers grants that support the clinical and/or research training of health professionals (nurses, physicians, and social workers). Our goal is to support and promote high impact and innovative cancer research across a wide range of disciplines to meet critically important needs in the control of cancer. 

The American Cancer Society Extramural Research program currently supports 739 grants research and training grants totaling $417.4 million in a wide range of cancer-related disciplines at more than 200 institutions. With an investment of more than $4.8 billion since 1946, the ACS is the largest private, not-for-profit source of cancer research funds in the United States.

Examples of current grant mechanisms include:

  • Research Scholar Grant: Investigators in the first 6 years of an independent research career or faculty appointment; eligibility extends to 8 years for clinician scientists. Up to 4 years at $165K/year for direct costs, plus 20% indirect costs.
  • Clinician Scientist Development Grant: Full-time clinician scientists within the first 6 years of their first faculty appointment. $135K direct costs, plus 8% indirect costs per year for 3 to 5 years.
  • Postdoctoral Fellowship: Investigators within 3 years of receiving a doctoral degree who are US citizens or permanent residents. Awards may be for 3 years with newly increased progressive stipends of $52,000, $54,000, and $56,000 per year. Includes newly updated additional benefits.

For a complete list of American Cancer Society grant mechanisms and more information about the funding process, please visit https://www.cancer.org/research/we-fund-cancer-research/apply-research-grant.html.


The Taub Foundation Grants Program for MDS Research

Applications due October 15

Program Overview: The Taub Foundation Grants Program for Myelodysplastic Syndromes (MDS) Research was created to support high-impact, innovative, translational research to understand the underlying causes of MDS and to advance its treatment and prevention. Innovative studies with transformative potential to elucidate MDS etiology and to develop new treatments are particularly encouraged. Proposals focused on the progression of MDS to AML are not within the scope of this funding.

The Taub Program supports independent investigators at all stages of their careers. To promote the expansion of the MDS research field collaborative efforts and proposals from young investigators and those from non-MDS fields are encourage to apply.  

Award Amount: $600,000 over three years ($200,000 per year)

Funding Period: July 1, 2020 - June 30, 2023

Eligibility:

  • Applicants must hold a Ph.D., M.D., M.D./Ph.D., or equivalent degree, and a faculty appointment at a non-profit academic, medical, or research institution in the United States.
  • Applicants must be independent investigators with institutional support and their own laboratory.
  • Applicants may not have funding support for a similar project.

United States citizenship is not required; visa documentation is not required.

Deadline: October 15, 12:00 Noon ET (Invited full proposals will be due March 2020)


American Heart Association 2020 Career Development Award

Applications due October 15

Statement of Purpose: Supports highly promising healthcare and academic professionals, in the early years of one’s first professional appointment, to explore innovative questions or pilot studies that will provide preliminary data and training necessary to assure the applicant’s future success as a research scientist. The award will develop the research skills to support and greatly enhance the awardee’s chances to obtain and retain a high-quality career position.

Science Focus: The AHA funds basic, clinical, behavioral, translational and population research, bioengineering/biotechnology and public health problems broadly related to fulfilling our mission to be a relentless force for a world of longer, healthier lives..

Disciplines: AHA awards are open to the array of academic and health professionals. This includes but is not limited to all academic disciplines (biology, chemistry, mathematics, technology, physics, etc.) and all health-related professions (physicians, nurses, advanced practice nurses, pharmacists, dentists, physical and occupational therapists, statisticians, nutritionists, behavioral scientists, engineers, etc.). Clinical, translational, population, behavioral, and basic scientists are encouraged to apply AHA strongly encourages applications by women, underrepresented minorities in the sciences, and those who have experienced diverse and non-traditional career trajectories.

Eligibility: At the time of application, the applicant must hold an M.D., Ph.D., D.O., D.V.M., D.D.S., or equivalent post-baccalaureate doctoral degree.

  • Postdoctoral fellows are eligible to apply and must have attained faculty appointment by the time of award activation.
  • The AHA will permit a Career Development Awardee to concurrently hold an NIH K award. if there is no budgetary overlap. NIH K99/R00 awardees may apply if they will be in the R00 stage of the award at time of AHA Career Development Award activation.

At the time of award activation:

  • An awardee must hold a faculty/staff position up to and including the rank of assistant professor (or equivalent).
  • No more than five years may have elapsed since the first faculty/staff appointment (after receipt of doctoral degree) at the assistant professor level or equivalent (including, but not limited to, instructor, research assistant professor, research scientist, staff scientist, etc.).
  • While no minimum percent effort is required, the applicant must demonstrate that adequate time will be devoted to ensuring successful completion of the project.

NCI Research Specialist Award (R50)

Applications due October 18

The NCI Research Specialist Award encourages the development of stable research career opportunities for exceptional scientists who want to pursue research within the context of an existing cancer research program, but not serve as independent investigators.  These scientists, including researchers within a research program, core facility managers, and data scientists, are vital to sustaining the biomedical research enterprise.  The Research Specialist Award is intended to provide salary support and sufficient autonomy so that individuals are not solely dependent on NCI grants held by others for career continuity.

Two Funding Opportunity Announcements (FOAs) invite grant applications for the Research Specialist Award (R50) in any area of NCI-funded cancer research.

FOA for laboratory-based scientists

FOA for core-based scientists


Human Vaccines Project- 2020 Michelson Prize

Pre-applications due October 31

Interested applicants are encouraged to contact Erin Morrison (VUMCDEV Corporate & Foundation Relations) for assistance with proposal development

The Human Vaccines Project Michelson Prize is a scientific award of $150,000 given to young investigators who are applying disruptive concepts and inventive processes to advance human immunology, vaccine discovery, and immunotherapy research across major global diseases. Michelson Prizes are open to early-career researchers under 35 at the time of application.

The 2020 Michelson Prize will focus on advances in human immunology to accelerate the development of more effective vaccines and immunotherapies. They seek high-impact and highly innovative research that has the potential to be applied across many diseases and to significantly expand our understanding of the human immune system.

Pre-applications for the 2020 Michelson Prizes will be accepted from September 9 – October 31, 2019. There is no institutional application process required. Learn more on the Michelson Prize site.


BrightFocus Foundation Alzheimer's Disease Research Grant

 

Applications due November 4

 

Interested applicants are encouraged to contact Jenny Alexander (VUMCDEV Corporate & Foundation Relations) for assistance with proposal development

 

BrightFocus Foundation has issued an RFP for grant funding in Alzheimer's Disease Research with a deadline of November 4, 2019.

https://www.brightfocus.org/ADR-RFP

 

BrightFocus provides research funds for U.S. domestic as well as international researchers pursuing pioneering research leading to greater understanding, prevention, and treatment of Alzheimer's disease.

 

Typically these awards are made to early stage investigators, or to more established investigators who are proposing particularly innovative research.

 

Full proposal deadline: 4 November 2019, 5:00 PM EST

 

Amount: $100,000 per year

 

Award durations: Standard Awards can be up to 3 years. Fellowship Awards can be up to 2 years.

 

Eligibility: All scientists working at non-profit and government laboratories are eligible to apply for a Standard Award. Fellowships are limited to researchers within 5 years of doctoral degree conferral (or end of residency).

 

The full announcement may be viewed at https://www.brightfocus.org/ADR-RFP.


Crohn’s & Colitis Foundation Litwin IBD Pioneers Award

Letters of Intent due November 5

The Award supports innovative clinical and translational research projects with the potential to impact the treatment of IBD patients in the near future. The program encourages novel research into the diagnosis, identification of clinically relevant subsets, treatments, and cures for inflammatory bowel diseases (IBD) and funds innovative pilot research so that scientists can test their initial ideas and generate preliminary data.

Litwin IBD Pioneers supports researchers who are exploring all possible opportunities for diagnostic and therapeutic improvements, including novel, out-of-the-box ideas, and funds innovative and pioneering ideas that have a clinically relevant focus. Additionally, the program is open to investigators from other disciplines new to the IBD field, as well as countries outside the United States.

There is no fixed upper or lower limit of funding, but awards are generally not funded above $130,000, including 10% indirect costs, for clinical trials; and above $110,000, including 10% indirect costs, for lab-based studies.


Cancer Research Institute Technology Impact Award

Letters of Intent due November 15

The Cancer Research Institute is requesting letters of intent for its Technology Impact Award. The program is designed to encourage collaboration between technology developers and clinical cancer immunologists in addressing the gap between technology development and clinical application of cancer immunotherapies. The ultimate aim of this program is to advance technologies that can speed up the entire field’s efforts in addressing one of the most defining challenges of our time—developing immunotherapies that are effective for all cancer patients.

The most competitive applicants will address areas where technological innovation stands to benefit the field and cancer patients most, and that will ultimately lead to effective next generation personalized cancer immunotherapies.

Applicants must hold a faculty appointment as a tenure-track assistant professor (or higher rank) at the time of award activation.

Successful candidates will be eligible for follow-on funding to enable established proof-of-concept technology to be developed into a methodology that improves cancer immunotherapy research worldwide.

LOI Deadline: November 15, 2019
Selected applicants will be invited to submit a full research proposal, due March 15, 2020.

Funding: $200,000 over two years


Doris Duke Charitable Foundation- 2020 Clinical Scientist Development Award

Pre-proposal applications due November 19

Interested applicants are encouraged to contact Jenny Alexander (VUMCDEV Corporate & Foundation Relations) for assistance with proposal development

Physician scientists pursuing research careers face challenges that are particular to their dual roles as researchers and health care providers. The purpose of the Doris Duke Clinical Scientist Development Award (CSDA) is to provide support to physician scientists at the Assistant Professor rank to: 1) conduct an outstanding clinical research project, 2) enable research time protection to ease the tension between research and clinical responsibilities, and 3) facilitate development of strong mentorship relations. Ultimately, the CSDA program aims to enable physician scientists’ achievement of independent and successful research careers.

The 2020 Clinical Scientist Development Award consists of $150,000 annual direct costs plus $15,000 (10%) annual indirect costs for three years.

This program supports clinical research projects in any disease area. In keeping with the wishes expressed in Doris Duke's will, experiments that use animals or tissues derived from animals, including cell lines, will not be supported by this program.

For full eligibility criteria, visit: https://www.ddcf.org/globalassets/medicalresearch/csda/2020-csda/2020-csda-rfa.pdf


Infectious Diseases Society of America Foundation- Alzheimer's Research Grant

Applications due November 30

Through partnership with Alzheimer’s Quest, Inc., The Benter Foundation, and the IDSA Foundation, ID investigators are called to submit their stellar research proposal addressing to identify a potential microbial link to Alzheimer’s disease. All application submissions must be narrowly focused on elucidating the possible roles of infectious agents in the causation of Alzheimer’s disease. The awards will support innovative research including basic, clinical, and/or non-traditional approaches.

PRIMARY PROGRAM OBJECTIVES
  • To obtain evidence that an infectious agent or microbial community is correlated to Alzheimer’s disease.
  • To promote novel research in the field of microbial triggers for Alzheimer’s disease.
ELIGIBILITY REQUIREMENTS
  • Both members and non-members of IDSA are encouraged to apply. This includes established investigators, academic and health professionals in all disciplines and health-related professions.
  • PhD and MDs are welcome to apply.
  • Interdisciplinary research is encouraged, including collaborations between experts in Alzheimer’s research and infectious diseases.
  • Clinical and basic scientists are encouraged to apply.
  • International applications are welcome.

Damon Runyon Physician-Scientist Training Award

Applications due December 2

Interested applicants are encouraged to contact Adele White (VUMCDEV Corporate & Foundation Relations) for assistance with proposal development

In an effort to confront the crisis arising from a growing dearth of physician-scientists, Damon Runyon wishes to encourage more physicians to pursue research careers. To do so, the Foundation established a program designed to recruit outstanding U.S. Specialty Board eligible physicians into cancer research careers by providing them with the opportunity for a protected research training experience under the mentorship of a highly qualified and gifted mentor after they have completed all of their clinical training. The goals are a) to transform these individuals into the highest quality physician-scientists, capable of conducting research that has the potential to transform the diagnosis, treatment and/or prevention of cancer and b) to eliminate the financial disincentive to entering this career path.

This award will provide a funding source that will enable these individuals to pursue research intensively (at least 80% effort) for up to four years, while, if they wish to maintain their clinical skills, continuing to be clinically active (no more than 20% effort). With the recognition that very few other funding sources (if any) exist to support these developing physician-scientists, this award is structured to provide recipients with significant salary support and necessary research expenses, with the expectation that their institutions will provide an environment and additional support (such as benefits and institutional overhead) to ensure their success. In addition, the Foundation will retire up to $100,000 of any medical school debt still owed by an award recipient.

Eligibility Notes: 

  • Only one Physician-Scientist Training Award application will be accepted from a Mentor per review session; there is no limit, however, to the number of applications from an institution.
  • No more than two awardees will be funded to work with the same Mentor at any given time.
  • Eligible candidates may apply up to two times.